MAPT and Alzheimer disease: Ninety-four individuals (25 cognitively unimpaired (CU) young, 28 CU elderly, 15 MCI, and 26 AD dementia) were studied with [11C]Martinostat PET, MRI, and cognitive assessments; a subset had amyloid-β PET and tau PET.